Sicart Associates LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1696494 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$4,309,908

-$1,068,439 QoQ

Shares Held

6,912

-0.7% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

#408

of 1,322 holders

Holding Since

Mar 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sicart Associates LLC holds $19,051,494 across 4 Biotechnology names. REGN ranks #2 (22.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	160,694	$12,741,427
2	REGN	Regeneron Pharmaceuticals, Inc. This page	6,912	$4,309,908
3	CGON	CG Oncology, Inc.	25,000	$1,776,250
4	PTCT	Ptc Therapeutics, Inc.	2,745	$223,909

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,309,908	6,912	-0.7%	Shares	Sole	2026-08-11
2026-03-31	$5,378,347	6,961	0.0%	Shares	Sole	2026-04-21
2025-12-31	$5,372,987	6,961	-0.3%	Shares	Sole	2026-01-14
2025-09-30	$3,925,206	6,981	+1566.1%	Shares	Sole	2025-10-07
2024-03-31	$403,283	419	0.0%	Shares	Sole	2024-05-03
2023-12-31	$368,003	419	0.0%	Shares	Sole	2024-01-19
2023-09-30	$344,820	419	0.0%	Shares	Sole	2023-10-26
2023-06-30	$301,068	419	-10.3%	Shares	Sole	2023-07-28
2023-03-31	$383,719	467	-0.6%	Shares	Sole	2023-05-09
2022-12-31	$339,100	470	0.0%	Shares	Sole	2023-01-27
2022-09-30	$323,768	470	-10.6%	Shares	Sole	2022-11-02
2022-06-30	$310,934	526	-2.2%	Shares	Sole	2022-08-05
2022-03-31	$375,749	538	-41.5%	Shares	Sole	2022-05-06
2021-12-31	$580,998	920	-12.2%	Shares	Sole	2022-01-31
2021-09-30	$634,228	1,048	-1.4%	Shares	Sole	2021-10-22
2021-06-30	$593,728	1,063	0.0%	Shares	Sole	2021-07-23
2021-03-31	$502,947	1,063	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.